• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶酶体贮积症中的乳糖神经酰胺:一项比较性免疫组织化学和生物化学研究。

Lactosylceramide in lysosomal storage disorders: a comparative immunohistochemical and biochemical study.

作者信息

Hůlková H, Ledvinová J, Asfaw B, Koubek K, Kopriva K, Elleder M

机构信息

Institute of Inherited Metabolic Disorders, Charles University, First Faculty of Medicine and University Hospital, Ke Karlovu 2 128 08, 128 08, Prague 2, Czech Republic.

出版信息

Virchows Arch. 2005 Jul;447(1):31-44. doi: 10.1007/s00428-005-1246-y. Epub 2005 May 26.

DOI:10.1007/s00428-005-1246-y
PMID:15918012
Abstract

Immunohistochemical studies of the presence of lactosylceramide (LacCer) in lysosomal storage disorders (LSDs) were done using anti-LacCer monoclonal antibody of the CDw 17 type (clone MG-2). No sign of an association between LacCer and the lysosomal system in normal cells was observed, except for histiocytes active in phagocytosis. A comparative study of a group of LSDs showed a general tendency for LacCer to increase in storage cells in Niemann-Pick disease type C (NPC), and types A and B, GM1 gangliosidosis, acid lipase deficiency, glycogen storage disease type II and mucopolysaccharidoses. LacCer accumulated in storage cells despite normal activity of relevant lysosomal degrading enzymes. The accumulation of LacCer displayed variability within storage cell populations, and was mostly expressed in neurons in NPC. An absence of the increase in LacCer in storage cells above control levels was seen in neuronal ceroid lipofuscinoses (neurons and cardiocytes) and in Fabry disease. Gaucher and Krabbe cells showed significantly lower levels, or even the absence, of LacCer compared with control macrophages. Results of immunohistochemistry were corroborated by semiquantitative lipid thin-layer chromatography (TLC). It is suggested that different associations of LacCer with the lysosomal storage process may reflect differences in glycosphingolipid turnover induced by the storage-compromised lysosomal/endosomal system.

摘要

利用CDw 17型抗乳糖基神经酰胺(LacCer)单克隆抗体(克隆MG-2),对溶酶体贮积症(LSDs)中LacCer的存在情况进行了免疫组织化学研究。除了活跃于吞噬作用的组织细胞外,在正常细胞中未观察到LacCer与溶酶体系统之间存在关联的迹象。对一组LSDs的比较研究表明,在C型尼曼-匹克病(NPC)、A型和B型、GM1神经节苷脂病、酸性脂肪酶缺乏症、II型糖原贮积病和黏多糖贮积症中,LacCer在贮积细胞中有普遍增加的趋势。尽管相关溶酶体降解酶活性正常,但LacCer仍在贮积细胞中蓄积。LacCer的蓄积在贮积细胞群体中表现出变异性,且在NPC的神经元中表达最为明显。在神经元蜡样脂褐质沉积症(神经元和心肌细胞)和法布里病中,未观察到贮积细胞中LacCer增加至对照水平以上。与对照巨噬细胞相比,戈谢细胞和克拉伯细胞显示出LacCer水平显著降低,甚至缺失。免疫组织化学结果得到了半定量脂质薄层色谱(TLC)的证实。提示LacCer与溶酶体贮积过程的不同关联可能反映了由贮积受损的溶酶体/内体系统诱导的糖鞘脂周转差异。

相似文献

1
Lactosylceramide in lysosomal storage disorders: a comparative immunohistochemical and biochemical study.溶酶体贮积症中的乳糖神经酰胺:一项比较性免疫组织化学和生物化学研究。
Virchows Arch. 2005 Jul;447(1):31-44. doi: 10.1007/s00428-005-1246-y. Epub 2005 May 26.
2
A Comparative Study on the Alterations of Endocytic Pathways in Multiple Lysosomal Storage Disorders.多种溶酶体贮积症内吞途径改变的比较研究
Mol Pharm. 2016 Feb 1;13(2):357-368. doi: 10.1021/acs.molpharmaceut.5b00542. Epub 2016 Jan 11.
3
Properties and functions of lactosylceramide from mouse neutrophils.来自小鼠中性粒细胞的乳糖神经酰胺的特性与功能。
Glycobiology. 2015 Jun;25(6):655-68. doi: 10.1093/glycob/cwv008. Epub 2015 Jan 16.
4
Biotherapeutic target or sink: analysis of the macrophage mannose receptor tissue distribution in murine models of lysosomal storage diseases.生物治疗靶点或清除途径:溶酶体贮积病小鼠模型中巨噬细胞甘露糖受体组织分布的分析。
J Inherit Metab Dis. 2011 Jun;34(3):795-809. doi: 10.1007/s10545-011-9285-9. Epub 2011 Mar 17.
5
Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils.含超长脂肪酸的乳糖神经酰胺在乳糖神经酰胺介导的中性粒细胞超氧化物生成和迁移中的作用。
Glycoconj J. 2008 May;25(4):357-74. doi: 10.1007/s10719-007-9084-6. Epub 2007 Nov 28.
6
Free sphingoid bases in tissues from patients with type C Niemann-Pick disease and other lysosomal storage disorders.C型尼曼-匹克病及其他溶酶体贮积症患者组织中的游离鞘氨醇碱
Biochim Biophys Acta. 1994 May 25;1226(2):138-44. doi: 10.1016/0925-4439(94)90021-3.
7
Broad screening test for sphingolipid-storage diseases.鞘脂贮积病的广泛筛查试验。
Lancet. 1999 Sep 11;354(9182):901-5. doi: 10.1016/S0140-6736(98)10034-X.
8
Lactosylceramide-accumulation in lipid-rafts mediate aberrant-autophagy, inflammation and apoptosis in cigarette smoke induced emphysema.乳糖基神经酰胺在脂筏中的积累介导了香烟烟雾诱导的肺气肿中的异常自噬、炎症和细胞凋亡。
Apoptosis. 2015 May;20(5):725-39. doi: 10.1007/s10495-015-1098-0.
9
Intracellular localization of lactosylceramide, the major human neutrophil glycosphingolipid.
J Biol Chem. 1987 Aug 15;262(23):11356-63.
10
[Lysosomal storage diseases: A brief summary].[溶酶体贮积症:简要概述]
Pathologe. 2015 Sep;36(5):485-93. doi: 10.1007/s00292-015-0053-8.

引用本文的文献

1
Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A.鞘磷脂大量积累影响溶酶体和线粒体区室并促进尼曼-匹克病 A 型细胞凋亡。
J Mol Neurosci. 2022 Jul;72(7):1482-1499. doi: 10.1007/s12031-022-02036-4. Epub 2022 Jun 21.
2
Biomarkers in Glycogen Storage Diseases: An Update.糖原贮积病中的生物标志物:最新进展
Int J Mol Sci. 2021 Apr 22;22(9):4381. doi: 10.3390/ijms22094381.
3
Elevated LysoGb3 Concentration in the Neuronopathic Forms of Mucopolysaccharidoses.

本文引用的文献

1
Accumulation of a glycerolphospholipid in classical niemann-pick disease.经典型尼曼-匹克病中甘油磷脂的蓄积。
Lipids. 1968 May;3(3):287-90. doi: 10.1007/BF02531203.
2
Structural basis for glycosphingolipid transfer specificity.糖鞘脂转移特异性的结构基础。
Nature. 2004 Aug 26;430(7003):1048-53. doi: 10.1038/nature02856.
3
Secondary accumulation of gangliosides in lysosomal storage disorders.神经节苷脂在溶酶体贮积症中的继发性蓄积。
黏多糖贮积症神经病变型中溶菌酶Gb3浓度升高。
Diagnostics (Basel). 2020 Mar 13;10(3):155. doi: 10.3390/diagnostics10030155.
4
Lysosomal Re-acidification Prevents Lysosphingolipid-Induced Lysosomal Impairment and Cellular Toxicity.溶酶体再酸化可预防溶血鞘脂诱导的溶酶体损伤和细胞毒性。
PLoS Biol. 2016 Dec 15;14(12):e1002583. doi: 10.1371/journal.pbio.1002583. eCollection 2016 Dec.
5
A murine Niemann-Pick C1 I1061T knock-in model recapitulates the pathological features of the most prevalent human disease allele.一种小鼠尼曼-匹克C1 I1061T基因敲入模型概括了最常见的人类疾病等位基因的病理特征。
J Neurosci. 2015 May 27;35(21):8091-106. doi: 10.1523/JNEUROSCI.4173-14.2015.
6
Secondary lipid accumulation in lysosomal disease.溶酶体疾病中的继发性脂质蓄积
Biochim Biophys Acta. 2009 Apr;1793(4):726-36. doi: 10.1016/j.bbamcr.2008.11.014. Epub 2008 Dec 9.
Semin Cell Dev Biol. 2004 Aug;15(4):433-44. doi: 10.1016/j.semcdb.2004.03.002.
4
Role of LBPA and Alix in multivesicular liposome formation and endosome organization.LBPA和Alix在多囊泡脂质体形成和内体组织中的作用。
Science. 2004 Jan 23;303(5657):531-4. doi: 10.1126/science.1092425.
5
LIPIDS OF THE SPLEEN IN GAUCHER'S DISEASE.高雪氏病脾脏的脂质
J Lipid Res. 1965 Apr;6:211-9.
6
ISOLATION AND CHARACTERIZATION OF THE MAIN SPLENIC GLYCOLIPIDS IN THE NORMAL ORGAN AND IN GAUCHER'S DISEASE: EVIDENCE FOR THE SITE OF METABOLIC BLOCK.
J Neuropathol Exp Neurol. 1965 Apr;24:290-303. doi: 10.1097/00005072-196504000-00009.
7
Lactosylceramide-induced apoptosis in primary amnion cells and amnion-derived WISH cells.
J Soc Gynecol Investig. 2002 Sep-Oct;9(5):282-89. doi: 10.1016/s1071-5576(02)00172-7.
8
Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils.富含乳糖神经酰胺的糖鞘脂信号结构域介导人中性粒细胞产生超氧化物。
Blood. 2002 Aug 15;100(4):1454-64.
9
Sphingolipid transport: rafts and translocators.鞘脂转运:脂筏与转运蛋白
J Biol Chem. 2002 Jul 19;277(29):25855-8. doi: 10.1074/jbc.R200010200. Epub 2002 May 13.
10
Correlation among genotype, phenotype, and biochemical markers in Gaucher disease: implications for the prediction of disease severity.戈谢病的基因型、表型和生化标志物之间的相关性:对疾病严重程度预测的意义。
Mol Genet Metab. 2002 Jan;75(1):46-55. doi: 10.1006/mgme.2001.3269.